U.S. seeks patent protection for drugs, experts say

Published: 2006-09-04 06:59:00

Updated: 2006-09-04 06:59:00

Domestic experts claim that the oncoming Korea-U.S. negotiations on free trade accord will mainly focus on the U.S. demand for more transparency in the Korean government's process of selecting the drugs eligible for the positive list'' and an extension of the patent period for their drugs to incr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK